Animal only

Wolverine stack

A popular name for combining BPC-157 and TB-500. The combination itself has been tested in one rat study. A published human trial of the pair has not been shown.

No reel for this stack yet. The BPC-157 and TB-500 briefs each have their own.

What it is

The Wolverine stack is a popular name for combining BPC-157 and TB-500. It is a marketing name, not a formal study title. The question these pages ask is not only what each peptide has been studied for, but whether the combination itself has been studied. Open the library briefs for the two pieces: BPC-157 and TB-500.

Studied for

  • BPC-157 and TB-500, each on its own, mostly in animal or laboratory models of tissue repair. That record is set out on each library brief.
  • The two peptides used together, which has been tested in one exploratory rat study of Achilles tendon repair.
  • Human use of the pair, which so far appears only as clinic stories or small case series, not as a controlled trial.

The evidence

Animal only, for the combination. In one exploratory study of repaired Achilles tendons in rats, TB-500 alone improved some strength and tissue scores; adding BPC-157 did not improve outcomes beyond either peptide used alone. A published human trial of BPC-157 plus TB-500 has not been shown. Clinic stories and small case series are not a substitute for that trial. Each peptide also has its own animal-only record, which is set out on its library page. Neither peptide, and not this combination, is an FDA-approved medicine.

What this page will not do

  • “Wolverine” is a nickname. It is not evidence that the combination heals like a comic-book character, and we do not use it that way.
  • We do not give a dose, a route, a cycle, a protocol, or a place to buy either peptide or the pair.
  • A finding that two peptides were combined in a rat study is not a result in people, and that study did not show an added benefit from combining them.

Still open

  • Whether a controlled human study of the combination, with a stated size and duration, gets published.
  • Whether the one rat finding — no added benefit from combining the two — is repeated in other models.
  • How products labeled TB-500 relate to the full thymosin beta-4 protein used in some research. That identity question belongs on the TB-500 brief as well.

Educational content only. This page does not diagnose, treat, cure, or prevent anything, and it is not a dose. Talk with a licensed physician before starting, stopping, or changing any medication. Stacks reviewed November 2026.